Historical Stock Price
ETFs Holding PBYI »    Stock Splits Calendar »



Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
03/21/2024 $4.67 $5.39 $4.62 $5.35 1.17M
03/22/2024 $5.28 $5.55 $5.16 $5.33 924.20K
03/25/2024 $5.31 $5.72 $5.25 $5.59 738.40K
03/26/2024 $5.67 $5.68 $5.37 $5.60 528.50K
03/27/2024 $5.63 $5.74 $5.38 $5.58 357.80K
Puma Biotechnology is a biopharmaceutical company with a focus on the development and commercialization of products to enhance cancer care. Co. in-licenses from Pfizer, Inc., the global development and commercialization rights to PB272 (neratinib (oral)), PB272 (neratinib (intravenous)) and PB357. Neratinib is an irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2 and HER4. Co. is primarily focused on the development and commercialization of the oral version of neratinib, and its drug candidates are directed at the treatment of HER2-positive breast cancer and HER2 mutated cancers.
PBYI historical stock prices picture
Puma Biotechnology (PBYI) has the following price history information. Looking back at PBYI historical stock prices for the last five trading days, on March 21, 2024, PBYI opened at $4.67, traded as high as $5.39 and as low as $4.62, and closed at $5.35. Trading volume was a total of 1.17M shares. On March 22, 2024, PBYI opened at $5.28, traded as high as $5.55 and as low as $5.16, and closed at $5.33. Trading volume was a total of 924.20K shares. On March 25, 2024, PBYI opened at $5.31, traded as high as $5.72 and as low as $5.25, and closed at $5.59. Trading volume was a total of 738.40K shares. On March 26, 2024, PBYI opened at $5.67, traded as high as $5.68 and as low as $5.37, and closed at $5.60. Trading volume was a total of 528.50K shares. On March 27, 2024, PBYI opened at $5.63, traded as high as $5.74 and as low as $5.38, and closed at $5.58. Trading volume was a total of 357.80K shares.

PBYI Historical Stock Prices By Date:

PBYI historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Puma Biotechnology shares, starting with a $10,000 purchase of PBYI, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/31/2014
End date: 03/27/2024
Start price/share: $104.14
End price/share: $5.58
Dividends collected/share: $0.00
Total return: -94.64%
Average Annual Total Return: -25.38%
Starting investment: $10,000.00
Ending investment: $535.67
Years: 10.00
Date Close
03/21/2024$5.35
03/22/2024$5.33
03/25/2024$5.59
03/26/2024$5.60
03/27/2024$5.58
PBYI is categorized under the Healthcare sector; below are some other companies in the same sector:

PCRX Historical Stock Prices
PCYC Historical Stock Prices
PDCO Historical Stock Prices
PDEX Historical Stock Prices
PDII Historical Stock Prices
PEN Historical Stock Prices
PETX Historical Stock Prices
PFE Historical Stock Prices
PFNX Historical Stock Prices
PGNX Historical Stock Prices

Also explore: PBYI shares outstanding history

Email EnvelopeFree PBYI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

PBYI Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.